Navigation Links
Glucosamine-like supplement suppresses multiple sclerosis attacks
Date:9/30/2011

Irvine, Calif., Sept. 30, 2011 A glucosamine-like dietary supplement suppresses the damaging autoimmune response seen in multiple sclerosis, according to a UC Irvine study.

UCI's Dr. Michael Demetriou, Ani Grigorian and others found that oral N-acetylglucosamine (GlcNAc), which is similar to but more effective than the widely available glucosamine, inhibited the growth and function of abnormal T-cells that in MS incorrectly direct the immune system to attack and break down central nervous system tissue that insulates nerves.

Study results appear online in The Journal of Biological Chemistry.

Earlier this year, Demetriou and colleagues discovered that environmental and inherited risk factors associated with MS previously poorly understood and not known to be connected converge to affect how specific sugars are added to proteins regulating the disease.

"This sugar-based supplement corrects a genetic defect that induces cells to attack the body in MS," said Demetriou, associate professor of neurology and microbiology & molecular genetics, "making metabolic therapy a rational approach that differs significantly from currently available treatments."

Virtually all proteins on the surface of cells, including immune cells such as T-cells, are modified by complex sugar molecules of variable sizes and composition. Recent studies have linked changes in these sugars to T-cell hyperactivity and autoimmune disease.

In mouse models of MS-like autoimmune disease, Demetriou and his team found that GlcNAc given orally to those with leg weakness suppressed T-cell hyperactivity and autoimmune response by increasing sugar modifications to the T-cell proteins, thereby reversing the progression to paralysis.

The study comes on the heels of others showing the potential of GlcNAc in humans. One reported that eight of 12 children with treatment-resistant autoimmune inflammatory bowel disease improved significantly a
'/>"/>

Contact: Tom Vasich
tmvasich@uci.edu
949-824-6455
University of California - Irvine
Source:Eurekalert

Page: 1 2

Related biology news :

1. Popular herbal supplements may adversely affect chemotherapy treatment
2. BD Biosciences Introduces Chemically Defined Cell Culture Media Supplement that Increases Biopharmaceutical Protein Production
3. Vitamin D supplements found to be safe for healthy pregnant women
4. U of I study: Before you start bone-building meds, try dietary calcium and supplements
5. Are dietary supplements working against you?
6. Study finds usage of, recommendations for supplements common within various physician specialties
7. Offspring of female rats given folic acid supplements develop more breast cancer
8. The right food supplements during pregnancy?
9. Meta-analysis shows no heart benefits for folic acid supplements
10. Supplement produces a striking endurance boost
11. Otolaryngology -- Head and Neck Surgery Annual Meeting supplement now available
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... skin fungus linked to dandruff, eczema and other itchy, ... even further global reachesincluding Hawaiian coral reefs and the ... , A review in the scientific journal PLOS ... the fungi of the genus Malassezia in ... datasets from around the world. , University of Hawai,i ...
(Date:8/21/2014)... Mller the Fram Strait is a key region in the ... between Greenland and Svalbard warm Atlantic water flows to the ... cold Arctic water masses and sea ice push their way ... portion of the Atlantic water cools here on its way ... of the water caused in this manner drives the global ...
(Date:8/21/2014)... researchers at Louisiana Tech University has developed ... 3D printers and materials to fabricate custom ... chemotherapeutic compounds for targeted drug delivery. , ... research faculty from Louisiana Tech,s biomedical engineering ... filament extruders that can make medical-quality 3D ...
Breaking Biology News(10 mins):From dandruff to deep sea vents, an ecologically hyper-diverse fungus 2Arctic sea ice influenced force of the Gulf Stream 2Arctic sea ice influenced force of the Gulf Stream 3Louisiana Tech University researchers use 3D printers to create custom medical implants 2Louisiana Tech University researchers use 3D printers to create custom medical implants 3
... Studies has been awarded $A28m by the Australian Research Council ... three new research programs - People and Ecosystems, Ecosystem Dynamics: ... , Centre Director, Professor Terry Hughes said that "the vision ... reefs and their interaction with people, in order to foster ...
... In a recent study published in the Neural ... Feng Li and team from Zhongshan School of Medicine, ... targeting BACE1, the key enzyme in amyloid beta protein ... to construct a short hairpin (shRNA) expression plasmid against ...
... Those who fly to tropical shores this Christmas in search ... shell picked from the beach could potentially bring relief to ... cone snails, as they are known from their shape, are ... pioneering new study by researchers at the University of York, ...
Cached Biology News:Cone snails are for life and not just at Christmas 2
(Date:8/22/2014)... , Aug. 22, 2014 /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or ... periods ended June 30, 2014.  Biorem,s complete 2014 second quarter financial statements ... Financial Summary:Three-months ended June 30, , Six-months ended ... 2014 , 2013 , 2014 , ... 4,433 , 9,195 Gross profit , 56 , ...
(Date:8/22/2014)... Ophthalmic drug delivery technologies or ... endeavors as the anatomy, physiology and biochemistry of ... foreign substances. Ocular drug delivery technologies provide several ... minimal use of needles; also it enables high ... specific targeting within the ocular globe. On the ...
(Date:8/22/2014)... (PRWEB) August 22, 2014 Nerium ... products, is in the spotlight again. Nerium will ... and its NeriumFirmTM Body Contouring Cream to Hollywood’s ... Backstage Creations during the 66th Primetime Emmy® Awards. ... NAE-8® extract, third-party clinical trials show that NeriumAD ...
(Date:8/21/2014)... at the Institute for Molecular Medicine Finland (FIMM), ... developed a novel "man and machine" decision support ... aid was described in PLOS One ... based on computer vision algorithms similar to those ... of only the diagnostically most relevant areas. Tablet ...
Breaking Biology Technology:Biorem Reports 2014 Second Quarter Results 2Biorem Reports 2014 Second Quarter Results 3Ocular Drug Delivery Technologies Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 2Ocular Drug Delivery Technologies Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 3Ocular Drug Delivery Technologies Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 4Nerium International Joins Television’s Biggest Stars at Backstage Creations Giving Suite at the 66th Primetime Emmy Awards 2Nerium International Joins Television’s Biggest Stars at Backstage Creations Giving Suite at the 66th Primetime Emmy Awards 3A novel 'man and machine' decision support system makes malaria diagnostics more effective 2
... from $31.0 million in Q1,08 , - Home Market: $14.4 ... Gross Margin: 21%, up from 13% in Q1,08 , - ... 8 NxStage Medical, Inc. (Nasdaq: NXTM ), ... revenue for the first quarter of 2009 of $33.7 million, ...
... DIEGO, May 7 Cadence Pharmaceuticals, Inc. (Nasdaq: ... on in-licensing, developing and commercializing proprietary product candidates ... reported financial results for the first quarter ended ... development program for Acetavance(TM), our proprietary formulation of ...
... May 7 Encorium Group, Inc. ... contract research organization (CRO) that provides design, development, ... registries to many of the world,s leading pharmaceutical ... Ph.D. has been appointed Head Consultant of Encorium,s ...
Cached Biology Technology:NxStage Reports First Quarter 2009 Financial Results 2NxStage Reports First Quarter 2009 Financial Results 3NxStage Reports First Quarter 2009 Financial Results 4NxStage Reports First Quarter 2009 Financial Results 5NxStage Reports First Quarter 2009 Financial Results 6NxStage Reports First Quarter 2009 Financial Results 7NxStage Reports First Quarter 2009 Financial Results 8NxStage Reports First Quarter 2009 Financial Results 9NxStage Reports First Quarter 2009 Financial Results 10NxStage Reports First Quarter 2009 Financial Results 11Cadence Pharmaceuticals Reports First Quarter 2009 Financial Results 2Cadence Pharmaceuticals Reports First Quarter 2009 Financial Results 3Cadence Pharmaceuticals Reports First Quarter 2009 Financial Results 4Cadence Pharmaceuticals Reports First Quarter 2009 Financial Results 5Cadence Pharmaceuticals Reports First Quarter 2009 Financial Results 6Cadence Pharmaceuticals Reports First Quarter 2009 Financial Results 7Professor Hanna Nohynek Joins Encorium as Head Consultant of its Clinical Vaccine Research Team 2Professor Hanna Nohynek Joins Encorium as Head Consultant of its Clinical Vaccine Research Team 3Professor Hanna Nohynek Joins Encorium as Head Consultant of its Clinical Vaccine Research Team 4